These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 4231608)

  • 21. Fibrin plate method with reagents purified by affinity chromatography and its use for determination of fibrinolytic and other proteolytic activity in saliva, bile and plasma.
    Norén I; Ramström G; Wallén P
    Haemostasis; 1975; 4(2):110-24. PubMed ID: 1332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the proteolysis of fibrinogen and fibrin by Aspergillus ochraceus enzyme as compared to the action of plasmin.
    Teisseyre E; Latallo ZS; Kopeć M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):99-110. PubMed ID: 4134484
    [No Abstract]   [Full Text] [Related]  

  • 24. The plasminogen-plasmin system. 8. On the mechanism of chemical induction of fibrinolysis. Isolation of a latent plasminogen activator from human plasma.
    Tomikawa M; Abiko Y
    Thromb Diath Haemorrh; 1973 Feb; 29(1):50-62. PubMed ID: 4267738
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibrinolytic activities of euglobulins precipitated at pH 6.4,6.0, and 5.3.
    Hedlin AM; Monkhouse FC
    Can J Physiol Pharmacol; 1969 Nov; 47(11):935-40. PubMed ID: 4242858
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fibrinolysis: kinetics of the lysis of a fibrin clot].
    Daver J; Edmond E; Panak E; Ricoeur M
    Rev Eur Etud Clin Biol; 1970 Mar; 15(3):333-42. PubMed ID: 4246032
    [No Abstract]   [Full Text] [Related]  

  • 27. Determination of plasminogen in human plasma by the lysis time method.
    Berg W; Korsan-Bengtsen K; Ygge J
    Thromb Diath Haemorrh; 1966 Jul; 16(1):1-17. PubMed ID: 5989041
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro potentiation of urokinase-activated lysis of human fibrin clots.
    Singh K; Vézina C
    J Med; 1974; 5(6):297-302. PubMed ID: 4528600
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum inhibitors in fibrinolysis.
    Gallimore MJ
    Br J Haematol; 1975 Oct; 31(2):217-31. PubMed ID: 53065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
    Hawiger J; Niewiarowski S; Gurewich V; Thomas DP
    J Lab Clin Med; 1970 Jan; 75(1):93-108. PubMed ID: 4243578
    [No Abstract]   [Full Text] [Related]  

  • 31. [The fibrinolytic activity in Seegers' cattle prothrombin preparations. A contribution to the problem of the activation of cattle prothrombin by plasmin].
    Andrassy K; Egbring R; Egli H
    Thromb Diath Haemorrh; 1969 Nov; 22(2):377-90. PubMed ID: 4245334
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fibrinolysis, determination and interpretation].
    Maki M
    Rinsho Byori; 1970 Aug; 18(8):563-8. PubMed ID: 5466550
    [No Abstract]   [Full Text] [Related]  

  • 33. [A method for separation of plasminogen from bovine plasma fraction. I. With reference to some properties of the plasminogen].
    Okamoto U; Matumoto M
    Nihon Seirigaku Zasshi; 1971; 33(7):394-402. PubMed ID: 4255047
    [No Abstract]   [Full Text] [Related]  

  • 34. Release of fibrinopeptides from fibrinolytic fibrinogen fragment E.
    Peyer A; Straub PW
    Thromb Diath Haemorrh; 1973 May; 29(2):300-12. PubMed ID: 4271587
    [No Abstract]   [Full Text] [Related]  

  • 35. [Determination of serum inhibitors of fibrinolysis by the method of "standard clots"].
    Daver J; Albugues MJ; du Pasquier JP; Ricoeur M
    Pathol Biol (Paris); 1970; 18(11):687-94. PubMed ID: 4247466
    [No Abstract]   [Full Text] [Related]  

  • 36. Histochemistry and assay of plasminogen activator.
    Pandolfi M
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):254-60. PubMed ID: 4262311
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coagulation factors and components of the fibrinolytic system in lymph and blood in dogs.
    Leandoer L; Bergentz SE; Nilsson IM
    Thromb Diath Haemorrh; 1968 Mar; 19(1):129-35. PubMed ID: 5652223
    [No Abstract]   [Full Text] [Related]  

  • 39. Variation in assays of standard SK and plasmin preparations: evidence for and effect of variability of plasmins, plasminogen, and fibrinogen.
    Johnson AJ; Tse A; Skoza L
    Fed Proc; 1966; 25(1):34-41. PubMed ID: 4283648
    [No Abstract]   [Full Text] [Related]  

  • 40. Properties of thrombin and fibrinolysin lysed fibrin.
    Triantaphyllopoulos DC; Muirhead CR; Triantaphyllopoulos E
    Thromb Diath Haemorrh Suppl; 1969; 36():269-76. PubMed ID: 5375545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.